Kronos Bio, Inc. (KRON) Share-based Payment Arrangement, Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kronos Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $7.71 M, a 16.6% increase year-over-year.
  • Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $26.1 M, a 13% decline year-over-year.
  • Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25 M, a 19.8% decline from 2022.
  • Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31.1 M, a 18.8% increase from 2021.
  • Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $26.2 M, a 598% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $26.1 M $7.71 M +$1.1 M +16.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $25 M $5.17 M -$2.52 M -32.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $27.5 M $6.3 M -$1.17 M -15.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $28.7 M $6.91 M -$1.3 M -15.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $30 M $6.61 M -$1.18 M -15.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $31.1 M $7.69 M +$285 K +3.85% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $30.9 M $7.46 M +$324 K +4.54% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $30.5 M $8.21 M +$1.78 M +27.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $28.8 M $7.79 M +$2.55 M +48.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $26.2 M $7.4 M +$5.39 M +267% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $20.8 M $7.14 M +$5.88 M +469% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $14.9 M $6.43 M +$6.14 M +2095% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $8.8 M $5.24 M +$5.05 M +2686% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $3.75 M $2.02 M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $1.25 M +$1.23 M +5352% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $293 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $188 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $23 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.